Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 1

Status

Unknown 11Recruiting 8Terminated 5Completed 5Not yet recruiting 3Active not recruiting 2Withdrawn 1

Sponsor Class

OTHER 5UNKNOWN 1OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Head & Neck 2Gastrointestinal 2Breast 1

Conditions

Esophageal Squamous Cell Carcinoma 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1

Interventions

Cyclophosphamide 955Radiotherapy 847Cisplatin 756Gemcitabine 657Carboplatin 602Docetaxel 598Paclitaxel 585Bevacizumab 579Fluorouracil 504Oxaliplatin 458Rituximab 453Surveys and Questionnaires 449Capecitabine 440Dexamethasone 428Doxorubicin 423Etoposide 410Irinotecan 389Cytarabine 376Filgrastim 369pembrolizumab 327Leucovorin 305Nivolumab 295fludarabine phosphate 294Melphalan 288Magnetic Resonance Spectroscopy 280Blood Specimen Collection 279Peripheral Blood Stem Cell Transplantation 278Methotrexate 276Lenalidomide 276Cetuximab 269

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × TP protocol × Clear all
NCT04005170 2022-08-23

Combination of Toripalimab and Chemoradiotherapy in Esophageal Cancer

Sun Yat-sen University

Phase 2 Completed
42 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT02459457 2022-02-09

A Comparison of Paclitaxel-based Three Regimens Concurrent With Radiotherapy for Patients With Local Advanced Esophageal Cancer

Fudan University

Phase 3 Completed
321 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT01216111 2020-05-19

Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)

Fudan University

Phase 3 Completed
647 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Taizhou Hospital

Phase 1/2 Completed
48 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT00933387 2016-05-04

A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma

National Health Research Institutes, Taiwan

Phase 2 Completed
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡